Drug-drug Interactions With Anti-tuberculous Drugs

ConditionDrug-drug Interaction

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorCairo University

About this trial

This study aims to assess the prevalence and the outcome of prescribing drugs known to have major drug-drug interactions with anti-tuberculous drugs among Kasr Alainy tuberculous patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients diagnosed with tuberculosis and referred to Tuberculosis outpatient clinic, Kasr Alainy Faculty of Medicine, Cairo University, starting after the obtaining of the Scientific/Ethical approval of the study protocol.

Disqualifiers

Refusal by the patient/patient's guardian to participate in this study

Trial population

Patients diagnosed with tuberculosis at the tuberculosis outpatient clinic at Kasr Alainy Faculty of Medicine, Cairo University

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Anti Tuberculosis Drug
Other intervention
1. Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients. 2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events).

Treatment groups

400 Participants

are divided into 1 treatment group

Group A: Tuberculous Patients1 intervention

Trial outcomes

Primary outcomes

Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients

Time frame

6 months

2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events).

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

Apply now